Artemis Medicare Services Ltd (ARTEMISMED) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Artemis Medicare Services Ltd on NSE and BSE, with an AI summary of each filing.
Audio Recording of Earnings Conference Call - Q2 and H2 FY27
Audio / Video · 02 Nov 2026, 10:55 pm
Artemis Medicare Releases Q2 and H1 FY27 Earnings Call Audio Recording Artemis Medicare Services Limited has made available the audio recording of its Earnings Conference Call conducted on 2nd Nov'26. The call reviewed the company's operational and financial performance for Q2 and H1 FY27, in compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. Investors can access the complete recording directly via the investor relations section on the company's official website.
Monitoring Agency Report for the quarter ended September 30, 2026
Others (Uncategorized) · 31 Oct 2026, 12:09 am
Artemis Medicare Services Q2FY27 Preferential Issue Monitoring Report CARE Ratings issued its monitoring report for Artemis Medicare Services' ₹330.00 crore preferential issue of Compulsorily Convertible Debentures for the quarter ended 30th Sep'26, confirming zero object deviations. Cumulative fund utilization reached ₹164.70 crore, with ₹10.36 crore deployed in Q2FY27 towards capex, medical equipment, and hospital construction. The unutilized balance of ₹165.30 crore remains deployed across fixed deposits and a monitoring account. Additionally, the tentative utilization timeline has been extended by 18 months to 15th Nov'27 via an earlier board resolution.
Earnings Presentation - Q2 and H1 FY27
Investor Presentation · 30 Oct 2026, 11:55 pm
Artemis Medicare Services Reports Q2 and H1 FY27 Financial Results Artemis Medicare Services delivered consolidated Q2 FY27 revenue from operations of INR 31,104 Lacs, rising 13.2% YoY and 8.3% QoQ. Consolidated EBITDA stood at INR 6,289 Lacs (up 7.9% YoY), while adjusted EBITDA reached INR 7,150 Lacs (up 22.7% YoY) with a 23.3% margin. Q2 PAT rose 3.7% YoY to INR 3,110 Lacs. For H1 FY27, revenue reached INR 59,836 Lacs (up 13.0% YoY) and PAT expanded 22.2% YoY to INR 6,254 Lacs. Bed capacity is targeted to expand to ~2,000 by 2030.
Press Release - October 30, 2026
Press Release · 30 Oct 2026, 11:42 pm
Artemis Medicare Reports Q2 FY27 Financial Results Artemis Medicare Services reported consolidated Q2 FY27 revenue of Rs 31,104 Lacs, up 13.2% YoY and 8.3% QoQ. Consolidated EBITDA rose 7.9% YoY to Rs 6,289 Lacs, while adjusted EBITDA (excluding the new Raipur unit) grew 22.7% YoY to Rs 7,150 Lacs. PAT stood at Rs 3,110 Lacs, up 3.7% YoY but down 1.1% QoQ, with diluted EPS at Rs 1.96. The flagship Gurugram hospital posted 14.5% YoY revenue growth, with bed occupancy improving to 68.1% and ARPOB rising to Rs 86,631.
Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter/ half year ended September 30, 2026
Financial Result · 30 Oct 2026, 11:33 pm
Artemis Medicare Q2 FY27 Financial Results and Operations Update Artemis Medicare Services reported consolidated Q2 revenue from operations of ₹31,104.14 lacs for the quarter ended 30th Sep'26, up 13.2% YoY from ₹27,470.28 lacs and 8.3% QoQ from ₹28,732.35 lacs. Net profit after tax reached ₹3,109.95 lacs versus ₹3,000.22 lacs in Q2 prior year and ₹3,144.27 lacs in Q1. H1 revenue grew 13.0% YoY to ₹59,836.49 lacs, while H1 PAT climbed 22.2% YoY to ₹6,254.22 lacs. During the quarter, the company soft-launched a new 300-bed multi-super speciality hospital in Raipur, Chhattisgarh.
Artemis Medicare Services Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 30 Oct 2026, 11:15 pm
Artemis Medicare Services Reports Q2 FY27 Results With Steady Revenue and Profit Growth Artemis Medicare Services reported consolidated revenue from operations of ₹311.04 crore for Q2 ended 30th Sep'26, up 13.23% YoY from ₹274.70 crore and 8.25% QoQ from ₹287.32 crore. Consolidated Net Profit stood at ₹31.10 crore, rising 3.66% YoY but declining 1.09% QoQ. H1 revenue grew 12.97% YoY to ₹598.36 crore, with PAT increasing 22.15% YoY to ₹62.54 crore. Operations commenced at its new 300-bed multi-super speciality hospital in Raipur, Chhattisgarh in Jul'26. Basic EPS for Q2 stood at ₹1.96.
Outcome of Board Meeting held on October 30, 2026
Outcome · 30 Oct 2026, 11:10 pm
Artemis Medicare Services Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs) ■ Revenue: 31,104 (+13.2% YoY | +8.3% QoQ) ■ EBITDA: 5,482 (+8.3% YoY | -2.9% QoQ) ■ EBITDA Margin (%): 17.6 (-80 bps YoY | -202 bps QoQ) ■ PAT: 3,103 (+3.5% YoY | -0.9% QoQ) ■ EPS (INR): 1.96 (+3.7% YoY | -1.0% QoQ)
Intimation of schedule of Earnings Conference Call - Q2 and H1 FY27
Intimation · 02 Nov 2026, 11:00 am
Artemis Medicare Services Schedules Q2 and H1 FY27 Earnings Call Artemis Medicare Services Limited has scheduled its earnings conference call on 2nd Nov'26 at 11:00 AM IST to discuss operational and financial performance for Q2 and H1 FY27. Hosted by Anand Rathi Research, key management participants include Managing Director Dr. Devlina Chakravarty, CFO Sanjiv Kumar Kothari, and Head of IR, M&A and Growth Strategy Rudra Narayan Acharjee. Primary universal access numbers for the call are 022 6280 1386 and 022 7115 8287.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 30 Oct 2026, 5:30 am
ARTEMIS MEDICARE SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 30 Oct 2026, 5:30 am
Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve the Un-audited Financial ....
Intimation · 30 Oct 2026, 5:30 am
Artemis Medicare Services Schedules Board Meeting for Q2 FY27 Financial Results Artemis Medicare Services Limited has scheduled a Board of Directors meeting on 30th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will remain shut until 1st Nov'26 (both days inclusive), reopening 48 hours post-declaration of the financial results.
Disclosure under Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 30 Sept 2026, 1:20 am
Artemis Medicare Receives Rs 11.11 Crore CGST Show Cause Notice Artemis Medicare Services received a Show Cause Notice dated 28th Sep'26 from the Assistant Commissioner, CGST, Gurugram, regarding FY23 with a claim of Rs 11.11 crore plus applicable interest and penalties. The authority alleged that the company charged MRP including GST on medicines, consumables, and implants supplied to in-patients without remitting the tax. Artemis is filing a writ petition before the High Court of Punjab & Haryana to tag the matter with an earlier writ where interim stay proceedings are already in place.
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 29 Sept 2026, 11:58 pm
Artemis Medicare Receives Rs 11.11 Crore CGST Show Cause Notice For FY23 Artemis Medicare Services received a Show Cause Notice dated 28th Sep'26 from CGST Gurugram for FY23 (1st Apr'22 to 31st Mar'23), raising tax claims of Rs 11.11 Crore plus interest and penalties. The department alleges the company charged MRP including GST on medicines, consumables, and implants provided to in-patients without remitting it to the government. Artemis plans to file a writ petition before the Punjab & Haryana High Court to tag this matter with an earlier writ on the same issue where interim stay was granted.
Intimation regarding reaffirmation of Credit Rating
Others (Uncategorized) · 24 Sept 2026, 6:29 pm
CARE Ratings Reaffirms Artemis Medicare's Credit Ratings for Bank Facilities CARE Ratings reaffirmed its credit ratings for Artemis Medicare Services Limited's bank facilities following a review of operational and financial performance up to Q1FY27. Long-term bank facilities of ₹343.15 crore (reduced from ₹427.90 crore) were reaffirmed at CARE A; Stable. Combined long-term/short-term facilities of ₹45.00 crore were reaffirmed at CARE A; Stable / CARE A2+. Total rated bank facilities stand at ₹388.15 crore, comprising term loans and overdraft limits across multiple lenders.
Analysts/ Institutional Investors' Conference - September 22, 2026
Intimation · 08 Sept 2026, 5:30 pm
Artemis Medicare to Participate in Anand Rathi Investor Conference Artemis Medicare Services Limited has scheduled its participation in the Anand Rathi Annual Flagship Conference G-200 Summit 2026. Company representatives will attend the event via physical interaction on 22nd Sep'26 in Mumbai. The schedule remains subject to changes based on exigencies from analysts, investors, or the company.
Analysts/ Institutional Investors' Conference - September 3, 2026
Intimation · 27 Aug 2026, 9:40 pm
Artemis Medicare to Meet Investors at PhillipCapital Conference Artemis Medicare Services Ltd. (ARTEMISMED) will participate in PhillipCapital's "Market Marvel | Investing Beyond the Headlines" conference. Company representatives are scheduled for a physical meeting with analysts and institutional investors on 3rd Sep'26 in Delhi. The schedule is subject to change based on any exigencies.
Transcript of Earnings Conference Call - Q1 FY27
Transcript · 10 Aug 2026, 7:13 pm
Analysts/ Institutional Investors' Conference - August 13, 2026
Intimation · 10 Aug 2026, 5:19 pm
Artemis Medicare to Participate in EMKAY Investor Conference Artemis Medicare Services Ltd. (NSE: ARTEMISMED) announced its participation in the EMKAY Confluence 2026 investor conference. Company representatives will attend the event, titled 'India: Full Throttle Ahead', in Mumbai on 13 Aug'26. The meeting with analysts and institutional investors will be conducted as a physical conference. The schedule is subject to potential changes.
Audio Recording of Earnings Conference Call - Q1 FY27
Audio / Video · 04 Aug 2026, 8:49 pm
Artemis Medicare Services Publishes Q1 FY27 Earnings Call Recording Artemis Medicare Services Ltd. has made the audio recording of its Q1 FY27 earnings conference call available on its website. The call, held on 4 Aug'26, discussed the company's operational and financial performance for the quarter ended Jun'26. This follows compliance with SEBI's Listing Obligations and Disclosure Requirements regulations. The link to the recording was provided in a regulatory filing to the NSE and BSE.
Monitoring Agency Report for the quarter ended June 30, 2026
Others (Uncategorized) · 03 Aug 2026, 11:58 pm
Artemis Medicare: Preferential Issue Fund Utilization and Timeline Extension Artemis Medicare submitted its Q1FY27 monitoring report for its ₹330 crore preferential issue. The company utilized ₹17.45 crore during the quarter for capex, leaving ₹175.66 crore unutilized. Key expenditures included ₹16.96 crore for medical equipment at Artemis Shanti Hospital, Raipur and ₹0.49 crore for VIMHANS Hospital, Delhi. The board has extended the fund utilization timeline by 18 months to Nov 15, 2027. CARE Ratings confirmed proceeds are used as per objectives with no deviations noted from the offer document.
Press Release - August 3, 2026
Press Release · 03 Aug 2026, 11:24 pm
Artemis Medicare Q1 FY27: Robust Profit and Revenue Growth Artemis Medicare Services reported strong Q1 FY27 consolidated results for the quarter ended 30-Jun'26. Revenue from operations grew 12.7% YoY to Rs 28,732 Lacs, while EBITDA increased 27.9% YoY to Rs 6,182 Lacs. PAT surged 48.3% YoY to Rs 3,144 Lacs, with diluted EPS rising 46.7% to Rs 1.98. Growth was driven by the flagship Gurgaon hospital, which saw a 15.4% YoY revenue increase, improved bed utilization at 65.7%, and higher ARPOB. The company also commenced operations at its new Raipur hospital in Jul'26.
Earnings Presentation-Q1 FY27
Investor Presentation · 03 Aug 2026, 11:20 pm
Artemis Medicare Reports Strong Q1 FY27 with Double-Digit Revenue and EBITDA Growth Artemis Medicare posted robust Q1 FY27 consolidated results, with revenue growing 12.7% YoY to ₹28,732 lacs and EBITDA up 36.4% YoY to ₹5,644 lacs. The EBITDA margin expanded by 341 bps to 19.6%, driven by strong operating leverage. Consequently, PAT surged 48.3% YoY to ₹3,144 lacs, with diluted EPS increasing 46.7% to ₹1.98. Key operational metrics for the Gurgaon unit improved, with occupancy at 65.7% (+443 bps YoY) and ARPOB rising 7.4% to ₹85,690, reflecting higher volumes and better realizations.
Intimation of proposed capacity expansion by adding 200+ beds through Tower IV in the Company''s flagship Hospital located at Sector-51, Gurugram
Others (Uncategorized) · 03 Aug 2026, 11:11 pm
Artemis Medicare Approves 200+ Bed Expansion at Gurugram Flagship Hospital Artemis Medicare's board approved Q1 FY27 results and a major capacity expansion on 03 Aug'26. The company will add 200+ beds to its flagship Gurugram hospital (Tower IV) over ~2 years, costing ₹160-180 crore, funded by internal accruals and debt. This expansion focuses on quaternary pediatric care and advanced gynecology/women's health. For Q1 FY27 (ended 30 Jun'26), consolidated PAT grew 48.3% YoY to ₹31.4 crore, while revenue from operations increased 12.7% YoY to ₹287.3 crore. Capacity utilization was 65.7%.
Un-audited Financial Results (Standalone and Consolidated) of the Company for the Quarter ended June 30, 2026
Financial Result · 03 Aug 2026, 10:58 pm
Artemis Medicare Approves Expansion Plan Amid Strong Q1 FY27 Results Artemis Medicare Services reported strong Q1 FY27 consolidated results with revenue at ₹287.3 Cr, up 12.7% YoY, and PAT at ₹31.4 Cr, up 48.3% YoY. The Board, in its meeting on 03 Aug'26, approved a significant expansion plan for its flagship Gurugram hospital. This involves adding 200+ beds over ~2 years, focusing on pediatrics and gynecology. The project requires a ₹160-180 Cr investment, funded by internal accruals and debt. Current capacity utilization for Q1 FY27 was 65.7%.
Outcome of Board Meeting held on August 3, 2026
Outcome · 03 Aug 2026, 10:46 pm
Artemis Medicare Services Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs) ■ Revenue: 28,732 (+12.7% YoY | +2.9% QoQ) ■ EBITDA: 5,644 (+36.4% YoY | +9.4% QoQ) ■ EBITDA Margin (%): 19.6 (+341 bps YoY | +117 bps QoQ) ■ PAT: 3,131 (+47.1% YoY | +4.3% QoQ) ■ EPS (INR): 1.98 (+46.7% YoY | +4.2% QoQ)